Cleo Diagnostics (ASX:COV) Buyback Yield % : -54.93 (As of May. 25, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Cleo Diagnostics's current buyback yield was -54.93%.

Cleo Diagnostics Buyback Yield % Historical Data

The historical data trend for Cleo Diagnostics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Buyback Yield % Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Buyback Yield %

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Buyback Yield %	-	-	-103.76

Competitive Comparison of Cleo Diagnostics's Buyback Yield %

For the Medical Devices subindustry, Cleo Diagnostics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Buyback Yield % falls into.

Cleo Diagnostics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Cleo Diagnostics's Buyback Yield for the fiscal year that ended in Jun. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	0
	=	N/A%

Cleo Diagnostics's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	12)	*	2	/	23.13
	=	-103.76%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2023) data.

Cleo Diagnostics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines